This study investigates the clinical outcomes and complications of treating central nervous system (CNS) infections using outpatient parenteral antimicrobial therapy (OPAT). CNS infections affect the brain and spinal cord, and can be serious. OPAT is a way to give antibiotics through a vein, outside of a hospital setting.
Participants in this study will receive treatment through an OPAT program. The study will monitor drug side effects and issues with the line used to deliver the medication. This helps understand how effective and safe OPAT is for treating CNS infections.
- Who can participate: The study is open to individuals aged 18 and older diagnosed with central nervous system infections who are eligible for outpatient parenteral antimicrobial therapy.
- Study details: Participants will receive antimicrobial therapy through an outpatient program. The study will track any drug side effects and complications related to the treatment line.
